Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection
Clinical trial NCT04340557 · COMPLETED
Trial details
- NCT number
- NCT04340557
- Sponsor
- Sharp HealthCare
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-27
- Primary completion
- 2020-06-13
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.